CDMO Experic has expanded its analytical laboratory and services.
The new 3,800 sqft laboratory, growing team of experienced scientific professionals, and additional investments in equipment and software will better support clients using the company’s formulation, development, and GMP manufacturing services.
Experic’s expertise resolving issues associated with challenging powder formulations requires specific talent and tools to deliver robust scientific solutions for both oral solid dose and inhalation products.
By expanding our team and capabilities, we can respond to clients more quickly and more cost effectively
“With our business growing rapidly, it became imperative to expand the laboratory,” said Justin Lacombe, Ph.D., Chief Scientific Officer at Experic. “Analytical services are integral to every development project and drug substance we work with. By expanding our team and capabilities, we can respond to clients more quickly and more cost effectively while providing a more complete end-to-end solution that clients want and need.”
Experic, a contract development and manufacturing organisation (CDMO) and pharmaceutical supply services company, supports every phase of a product’s life cycle from conception to clinical and commercial scale, across a range of dosing and packaging formats, including tablets, capsules, and low dose dry powder inhalation.
